Braxia Scientific Corp Stock Performance
| BRAXF Stock | USD 0 0 50.00% |
Braxia Scientific holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -1.86, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Braxia Scientific are expected to decrease by larger amounts. On the other hand, during market turmoil, Braxia Scientific is expected to outperform it. Use Braxia Scientific value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to analyze future returns on Braxia Scientific.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Braxia Scientific Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Braxia Scientific reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 11.1 M | |
| Total Cashflows From Investing Activities | -609 K |
Braxia |
Braxia Scientific Relative Risk vs. Return Landscape
If you would invest 0.20 in Braxia Scientific Corp on September 15, 2024 and sell it today you would earn a total of 0.10 from holding Braxia Scientific Corp or generate 50.0% return on investment over 90 days. Braxia Scientific Corp is currently producing 2.9% returns and takes up 23.1262% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Braxia, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Braxia Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Braxia Scientific's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Braxia Scientific Corp, and traders can use it to determine the average amount a Braxia Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1254
| Best Portfolio | Best Equity | |||
| Good Returns | BRAXF | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 23.13 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.9 actual daily | 57 57% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Braxia Scientific is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Braxia Scientific by adding it to a well-diversified portfolio.
Braxia Scientific Fundamentals Growth
Braxia Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Braxia Scientific, and Braxia Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Braxia Pink Sheet performance.
| Return On Equity | -1.02 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (4.42) % | |||
| Current Valuation | 4.7 M | |||
| Shares Outstanding | 240.72 M | |||
| Price To Book | 0.91 X | |||
| Price To Sales | 4.45 X | |||
| Revenue | 1.49 M | |||
| EBITDA | (6.91 M) | |||
| Cash And Equivalents | 7.68 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 52.55 K | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (4.52 M) | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 11.63 M | |||
About Braxia Scientific Performance
By analyzing Braxia Scientific's fundamental ratios, stakeholders can gain valuable insights into Braxia Scientific's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Braxia Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Braxia Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. Braxia Scientific Corp. is headquartered in Toronto, Ontario. Braxia Scientific operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Braxia Scientific Corp performance evaluation
Checking the ongoing alerts about Braxia Scientific for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Braxia Scientific Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Braxia Scientific is way too risky over 90 days horizon | |
| Braxia Scientific has some characteristics of a very speculative penny stock | |
| Braxia Scientific appears to be risky and price may revert if volatility continues | |
| Braxia Scientific has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.49 M. Net Loss for the year was (12.13 M) with profit before overhead, payroll, taxes, and interest of 246.87 K. | |
| Braxia Scientific Corp has accumulated about 7.68 M in cash with (4.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating ... |
- Analyzing Braxia Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Braxia Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Braxia Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Braxia Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Braxia Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Braxia Scientific's pink sheet. These opinions can provide insight into Braxia Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Braxia Pink Sheet analysis
When running Braxia Scientific's price analysis, check to measure Braxia Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Braxia Scientific is operating at the current time. Most of Braxia Scientific's value examination focuses on studying past and present price action to predict the probability of Braxia Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Braxia Scientific's price. Additionally, you may evaluate how the addition of Braxia Scientific to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |